These results are in agreement with previously published microarray datasets from patients with MDS and AML46, that showed that ZBTB38 mRNA is down-regulated in AML compared to control individuals (Supplementary Fig. S6A). This evidence concerns the gene ZBTB38 and acute myeloid leukemia.